Mark Löwenberg

1. HANŽEL, Jurij, DRESSEN, Erwin, VERMEIRE, Séverine, LÖWENBERG, Mark, HOENTJEN, Frank, BOSSUYT, Peter, CLASQUIN, Esmé, BAERT, Filip, D'HAENS, Geert, MATHÔT, Ron A. Pharmacokinetic-pharmacodynamic model of vedolizumab for targeting endoscopic remission in patients with crohn disease : posthoc analysis of the LOVE-CD study. Inflammatory bowel diseases. [Online ed.]. 2022, vol. 28, iss. 5, str. 689-699. ISSN 1536-4844. https://watermark.silverchair.com/izab044.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAr0wggK5BgkqhkiG9w0BBwagggKqMIICpgIBADCCAp8GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM6_bKi3zNnaQlGrP7AgEQgIICcExHuSHYpcRoXB5lzwHZeoJ-KbskLYT4n8eqAf09CyLhttps://academic.oup.com/ibdjournal/advance-article/doi/10.1093/ibd/izab143/6301858, Repository of the University of Ljubljana – RUL , DOI: 10.1093/ibd/izab143. [COBISS.SI-ID 67785475]

2. VERMEIRE, Séverine, HANŽEL, Jurij, LÖWENBERG, Mark, FERRANTE, Marc, BOSSUYT, Peter, HOENTJEN, Frank, FRANCHIMONT, Denis, PALATKA, Károly, PEETERS, Harald, MOOKHOEK, Aart. Early versus late use of vedolizumab in ulcerative colitis : clinical, endoscopic, and histological outcomes. Journal of Crohn's and colitis. Apr. 2024, vol. 18, iss. 4, str. 540-547. ISSN 1873-9946. https://academic.oup.com/ecco-jcc/advance-article-abstract/doi/10.1093/ecco-jcc/jjad179/7338812, DOI: 10.1093/ecco-jcc/jjad179. [COBISS.SI-ID 183640067]

3. HANŽEL, Jurij, NOVAK, Gregor, JAIRATH, Vipul, ZOU, Guangyong, DONG, Hannah, GUI, Xianyong Sean, HINDRYCKX, Pieter, BEATON, Melanie, BRESSLER, Brian, LÖWENBERG, Mark, et al. Directionality of endoscopic and histologic healing in ulcerative colitis : a prospective pilot study. European journal of gastroenterology & hepatology. Mar. 2025, vol. 37, iss. 3, str. 304-307. ISSN 0954-691X. https://journals.lww.com/eurojgh/abstract/2025/03000/directionality_of_endoscopic_and_histologic.8.aspx, DOI: 10.1097/MEG.0000000000002922. [COBISS.SI-ID 228508931]